Personalized Clinical Decision Making in Gastrointestinal Malignancies: The Role of PET

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Gastrointestinal malignancies comprise a heterogeneous group of diseases that include both common and rare diseases with very different presentations and prognoses. The mainstay of treatment is surgery in combination with preoperative and adjuvant chemotherapy depending on clinical presentation and initial stages. This article outlines the potential use of fluorodeoxyglucose-PET/CT in clinical decision making with special regard to preoperative evaluation and response assessment in gastric cancer (including the gastroesophageal junction), pancreatic cancer (excluding neuroendocrine tumors), colorectal cancer, and gastrointestinal stromal tumors.

OriginalsprogEngelsk
TidsskriftP E T Clinics
Vol/bind11
Udgave nummer3
Sider (fra-til)273-283
ISSN1556-8598
DOI
StatusUdgivet - 1. jul. 2016

Fingeraftryk Dyk ned i forskningsemnerne om 'Personalized Clinical Decision Making in Gastrointestinal Malignancies: The Role of PET'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater